Fumaric Acid

Fumaric Acid

SCHEMBL21436601

CC1(C)CNCCN1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.38
TP53 P04637 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
EGLN3 Q9H6Z9 1/20 0.38
HCAR2 Q8TDS4 1/20 0.32
LMNA P02545 2/20 0.32
BLM P54132 1/20 0.32
THRB P10828 2/20 0.31
CYP2C9 P11712 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ALPL P05186 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL21436329 0.85 ALPL (0.33) ALPL
Acetic Acid SCHEMBL1871815 0.85 ALPL (0.33) ALPL
Succinic Acid SCHEMBL21436621 0.79 EGLN1 (0.38) EGLN1LMNACYP2C9ALPL
Pivalate SCHEMBL28053669 0.79 ALPL (0.30) ALDH1A1ALPL
SCHEMBL64209 0.79
Cadaverine Tartrate SCHEMBL21436357 0.78 TSHR (0.40) TSHR
Hydrochloric Acid SCHEMBL3832428 0.77 ALPL (0.40) ALPL
Hydrochloric Acid SCHEMBL14335493 0.77
Ammonia Solution, Strong SCHEMBL21436559 0.77
Methylamine SCHEMBL27813413 0.74 ALPL (0.39) ALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147366-A1 PROCESS FOR PREPARATION OF 2,2-DIMETHYLPIPERAZINE H. LUNDBECK A/S (DK) 2021-05-20 US disclosed
EP-3774742-A1 PROCESS FOR THE PREPARATION OF 2,2-DIMETHYLPIPERAZINE H. Lundbeck A/S (DK) 2021-02-17 EP disclosed
CN-111868041-A Process for the preparation of 2, 2-dimethylpiperazine H.隆德贝克有限公司 2020-10-30 CN disclosed
WO-2019193134-A1 PROCESS FOR THE PREPARATION OF 2,2-DIMETHYLPIPERAZINE H. LUNDBECK A/S (DK) 2019-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147366-A1 PROCESS FOR PREPARATION OF 2,2-DIMETHYLPIPERAZINE CYP4F12, CYP4F2, CYP4F3 TSHR 910/4885TP53 1925/4885EGLN1 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.